Louisiana Board of Pharmacy - State of Louisiana

Print RSS Share This Site
photo-pharmacist State of Louisiana

Regulatory Proposals



2018-X
~ Amends multiple chapters of rules to implement Act 602 of the 2018 Legislature, which recognizes the use of chart orders by pharmacies serving patients in institutional healthcare facilities.
               11-07-2018 - Members reviewed stakeholder input and requested Draft #1 for its next committee meeting.


2018-W
~ Amends Chapter 1 ~ Introduction to identify rulemaking procedures for the Board, as required by Act 454 of the 2018 Legislature.
               10-18-2018 - Members reviewed Draft #1 and voted to recommend its approval by the Board.
               11-14-2018 - Board to consider the approval of Draft #1 for promulgation.


2018-V
~ Amends Chapter 27 ~ Controlled Dangerous Substances to create a CDS license for third-party logistics providers, as authorized by Act 186 of the 2018 Legislature.
               11-07-2018 - Members reviewed Draft #1 and voted to recommend its approval by the Board.
               11-14-2018 - Board to consider the approval of Draft #1 for promulgation.


2018-U
~ Amends Chapter 27 ~ Controlled Dangerous Substances to authorize the partial fill of prescriptions for all Schedule II medications, as authorized by Act 32 of the 2018 Legislature.
               10-18-2018 - Members reviewed Draft #1 and voted to recommend its approval by the Board.
               11-14-2018 - Board to consider the approval of Draft #1 for promulgation.


2018-T
~ Amends Chapter 29 - Prescription Monitoring Program to add an epidemiologist from the La. Dept. of Health to the list of persons authorized to access prescription monitoring information, for the purposes specified in Act 232 of the 2018 Legislature.
               10-18-2018 - Members reviewed Draft #1 and voted to recommend its approval by the Board.
               11-14-2018 - Board to consider the approval of Draft #1 for promulgation.


2018-S ~ Amends §507 in Chapter 5 - Pharmacists, to update the CE requirements by removing the requirement for pharmacists to maintain copies of their certificates at their primary practice sites, and to insert the requirement for pharmacists to maintain their CE records at CPE Monitor.
               09-13-2018 - Members voted to recommend the approval of Draft #1 to the Board.
               11-14-2018 - Board to consider the approval of Draft #1 for promulgation.


2018-R
~ Amends §903 and §905 in Chapter 9 - Pharmacy Technicians, to facilitate the licensing of pharmacy technicians originally licensed in another state, by removing the requirement for the applicant to obtain additional practical experience in this state.  Such applicants can be licensed in this state by proving at least one year of practice in the original state and successful completion of a board-approved pharmacy technician certification examination.
               09-13-2018 - Members voted to recommend approval of Draft #1 to the Board.
               11-14-2018 - Board to consider approval of Draft #1 for promulgation.       


2018-Q
~Amends §503 in Chapter 5 - Pharmacists as well as §903 in Chapter 9 - Pharmacy Technicians, to remove the one year delay following the third failure of a licensing examination.
               09-13-2018 - Members voted to recommend the approval of Draft #1 to the Board.
               11-14-2018 - Board to consider the approval of Draft #1 for promulgation.


2018-P
~ Creates a new §1129 - Louisiana Prescription Drug Prior Authorization Form; Requirements; Referral for Enforcement within Chapter 11 - Pharmacies, as required by Act 423 of the 2018 Legislature.
               08-15-2018 - Board approved Draft #4 for promulgation.
               08-20-2018 - Incorporated as Regulatory Project 2018-2.


2018-N
~ Amends §2535 in Chapter 25 - Prescriptions, Drugs, and Devices to establish standards for the compounding of copies of commercially-available products, in conformance with the final FDA Guidance Document on that topic issued in January 2018.
               11-07-2018 - Draft #1 on agenda for review by Regulation Revision Committee; not considered.


2018-M
~ Amends §521 in Chapter 5 - Pharmacists to establish standards for pharmacies and pharmacists hosting immunization activities.
               02-07-2018 - Draft #1 on agenda for review by Regulation Revision Committee.
               09-13-2018 - Members made minor amendments, then transferred all of the language in this proposal to Regulatory Proposal 2018-A ~ Immunizations.  Members then voted to recommend the approval of Draft #2 of Regulatory Poposal 2018-A to the Board.  As noted below, the Board will consider the approval of that regulatory proposal during their next meeting on 11-14-2018.


2018-L
~ Amends §2519 in Chapter 25 - Prescriptions, Drugs, and Devices to prohibit the dispensing of prescription refills in the absence of a patient's request.
               02-07-2018 - Draft #1 on agenda for review by Regulation Revision Committee.
               09-13-2018 - Members made minor amendments then voted to recommend the approval of Draft #2 to the Board.
               10-18-2018 - Members voted to reconsider their previous approval of Draft #2.
               11-07-2018 - Members reviewed Draft #3, selected one of the options offered, then voted to recommend the approval of Draft #4 to the Board.
               11-14-2018 - Board to consider the approval of Draft #4 for promulgation.


2018-K
~ Amends §1503 and 1517 in Chapter 15 - Hospital Pharmacy to authorize the issuance of a hospital pharmacy permit to a veterinary teaching hospital owned or operated by a public university in the state, and further, authorize such pharmacies to establish pharmacy security policies approved by the facility adminstration.
               02-07-2018 - Draft #1 on agenda for review by Regulation Revision Committee.
               09-13-2018 - Members made minor amendments then voted to recommend the approval of Draft #2 to the Board.
               11-14-2018 - Board to consider the approval of Draft #2 for promulgation.


2018-J
~ Creates a new §2914 - Record Retention of Prescription Transaction Information in Chapter 29 - Prescription Monitoring Program, in compliance with Act 189 of the 2016 Legislature, to establish standards for the retention, archiving, and destruction of prescription monitoring information.
               02-07-2018 - Draft #1 on agenda for review by Regulation Revision Committee.
               09-13-2018 - Members voted to recommend approval of Draft #1 to the Board.
               11-14-2018 - Board to consider approval of Draft #1 for promulgation.


2018-H
~ Amends several sections of Chapter 18 - Penal Pharmacy to comply with Act 310 of the 2016 Legislature, to authorize such pharmacies to accept returns of previously dispensed drugs from offenders in correctional centers owned and operated by law enforcement agencies, in addition to the current authority for such facilities owned and operated by the state department of corrections.  The amendments will also change the name from "penal" pharmacy to "correctional center" pharmacy.
               02-07-2018 - Draft #1 on agenda for review by Regulation Revision Committee.
               09-13-2018 - Members requested amendments and a second draft.
               10-18-2018 - Members reviewed Draft #2 then voted to recommend its approval by the Board.
               11-14-2018 - Board to consider approval of Draft #2 for promulgation.


2018-G
~ Amends §2425 - Telepharmacy Dispensing Site in Chapter 24 - Limited Service Providers to change the number of miles from the proposed dispensing site to the closest pharmacy, and further, requires such dispensing sites dispensing an annual average of 200 or more prescriptions per day to convert its permit to a community pharmacy permit prior to the expiration of its annual renewal.
               02-07-2018 - Draft #2 on agenda for review by Regulation Revision Committee.
               09-13-2018 - Draft #2 on agenda for review by Regulation Revision Committee; not considered.
               10-18-2018 - Members reviewed Draft #2 and requested additional research.
               11-07-2018 - Members reviewed Draft #3, made additional changes, then voted to recommend the approval of Draft #4 to the Board.
               11-14-2018 - Board to consider approval of Draft #4 for promulgation.


2018-F
~ Creates a new Subchapter F - Pharmacy Benefit Managers in Chapter 24 - Limited Service Providers to license and regulate pharmacy benefit managers.
               02-07-2018 - Committee reviewed Draft #1 and requested several amendments, then voted to recommend the approval of Draft #2 to the Board.
               02-21-2018 - Board approved Draft #2 for promulgatoin.
               05-20-2018 - Incorporated as Regulatory Project 2018-1.


2018-E
~ Amends the definition of "drugs of concern" in Chapter 29 - Prescription Monitoring Program to include naloxone.
               02-07-2018 - Draft #1 on agenda for review by Regulation Revision Committee.
               08-15-2018 - Board approved Draft #3 for promulgation.
               09-20-2018 - Incorporated as Regulatory Project 2018-3.


2018-D
~ Amends the relevant sections (§1105 in Chapter 11 - Pharmacies and §2307 in Chapter 23 - Nonresident Pharmacy) to require the pharmacist-in-charge report the arrival and departure of all credentialed persons (pharmacists, interns, technicians, candidates) practicing at that pharmacy, in written or electronic form, within 10 days of such arrivals and departures.
               02-07-2018 - Draft #1 on agenda for review by Regulation Revision Committee.
               09-13-2018 - Members requested an alternative approach to achieve the same outcome.
               10-18-2018 - Members reviewed Draft #2 then deferred further consideration pending development of a policy to enforce the curent law and rule requiring licensees to report their current mailing address and practice affiliation to the Board.
               11-14-2018 - Committee returned assignment to the Board with recommendation for policy document instead of new rule.


2018-C
~ Creates new §1529 in Chapter 15 - Hospital Pharmacy and amends §2505 of Chapter 25 - Prescriptions, Drugs, and Devices.  The new section will permit hospital pharmacies to manage investigational drug studies which may include persons who are not registered patients of that hospital.  The amendment of §2505 establishes standards for all pharmacies handling investigational drugs.
               02-07-2018 - Draft #1 on agenda for review by Regulation Revision Committee.
               09-13-2018 - Members vote to recommend approval of Draft #1 to the Board.
               11-14-2018 - Board to consider approval of Draft #1 for promulgation.


2018-B
~ Amends several sections of rules (§1519 in Chapter 15 - Hospital Pharmacy as well as §2503 and 2517 in Chapter 25 - Prescriptions, Drugs, and Devices) to permit pharmacies to accept returns of previously dispensed drugs for the purpose of destruction of such drugs.
               02-07-2018 - Draft #1 on agenda for review by Regulation Revision Committee.
               09-13-2018 - Members made minor adjustments and requested a second draft from the staff.
               10-18-2018 - Members reviewed Draft #2 and requested additional research.
               11-07-2018 - Members made additional changes and requested preparation of Draft #3 for review at next committee meeting.


2018-A
~ Amends Chapter 5 - Pharmacists, specifically §521 - Prescription Orders to Administer Medications, to require immunizing pharmacists or their designees to report their immunizations to the state immunization registry within 24 hours of the immunization, or in the event of mass immunization events, within 72 hours of such immunization.
               02-07-2018 - Draft #1 on agenda for review by Regulation Revision Committee.
               09-13-2018 - Members made minor amendments, then voted to recommend the approval of Draft #2 to the Board.
               11-14-2018 - Board to consider approval of Draft #2 for promulgation.


2016-H
~ Amends Chapter 27 - Controlled Dangerous Substances to streamline the reinstatement process for prescribing practitioners whose primary professional licenses were suspended or revoked by their primary professional licensing agency.
               11-16-2016 - Board voted to approve Draft #1 for promulgation, and further, voted to approve the Declaration of Emergency and set the effective date for the Emergency Rule as November 17, 2016.
               01-20-2017 - Incorporated as Regulatory Project 2016-5.
               05-20-2017 - Final Rule published, effective today.


2016-G
~ Amends Chapter 25 - Prescriptions, Drugs and Devices to create a new section §2514 - Standing Orders for the Distribution of Naloxone and Other Opioid Antagonists. Authorized by Act 370 of the 2016 Legislature, the new rule allows pharmacists to distribute naloxone or other opioid antagonists pursuant to nonpatient-specific standing orders issued by licensed medical practitioners.
               08-10-2016 - Board voted to approve Draft #1 for promulgation, and further, voted to approve the Declaration of Emergency and set the effective date for the Emergency Rule as August 10, 2016.
               12-07-2016 - Board re-issued Emergency Rule, effective today
               01-20-2017 - Incorporated as Regulatory Project 2016-4.
               05-20-2017 - Final Rule published, effective today.


2016-F ~ Amends Chapter 25 - Prescriptions, Drugs and Devices to amend §2519 - Prescription Refills with procedures for medication synchronization.
               01-19-2016 - Committee reviewed Draft #1 and requested one revision, then voted to recommend the approval of Draft #2 to the Board.
               02-24-2016 - Board voted to approve Draft #2 for promulgation, upon the instruction of the President.
               04-20-2016 - Incorporated as Regulatory Project 2016-3.
               09-20-2016 - Final Rule published, effective today.


2016-E ~ Amends Chapter 23 - Out-of-State Pharmacy to (a) implement technical changes from Act 282 of the 2013 Legislature, and (b) update the pharmacist-in-charge requirements for nonresident pharmacies to be consistent with the same requirements for pharmacies located within the state.
               01-19-2016 - Committee voted to recommend the approval of Draft #1 to the Board.
               02-24-2016 - Board voted to approve Draft #1 for promulgation, upon the instruction of the President.
               04-20-2016 - Incorporated as Regulatory Project 2016-2.
               01-20-2017 - Final Rule published, effective today.


2016-D ~ Amends Chapter 25 - Prescriptions, Drugs and Devices to implement Act 391 of the 2015 Legislature, which updated the definition of the term 'equivalent drug product' to now include biological products which have been rated as interchangeable biosimilars by the federal Food & Drug Administration.
               01-19-2016 - Committee scheduled to review Draft #1, but ran out of time.
               04-21-2016 - Committee reviewed Draft #1, requested no changes, then voted to recommend the approval of Draft #1 to the Board.
               05-04-2016 - Board approved Draft #1 for promulgation.
               04-20-2017 - Incorporated as Regulatory Project 2017-2.
               11-20-2017 - Final Rule published, effective today.


2016-C ~ Amends Chapter 25 - Prescriptions, Drugs and Devices as well as Chapter 27 ~ Controlled Dangerous Substances to (a) update the expiration date of controlled substance prescriptions in §2525, (b) implement Act 453 of the 2015 Legislature, which extended the controlled substance prescriptive authority for physician assistants and optometrists to include Schedule II, and (c) update the prescription format rules for controlled substance prescription forms used by mid-level practitioners to remove the requirement for the supervising physician's information to appear on the form.
               01-19-2016 - Committee voted to recommend the approval of Draft #1 to the Board.
               02-24-2016 - Board voted to approve Draft #1 for promulgation, upon the instruction of the President.
               04-20-2016 - Incorporated as Regulatory Project 2016-1.
               07-20-2016 - Final Rule published, effective today.


2016-B ~ Amends §705 of Chapter 7 - Pharmacy Interns, to change the practical experience requirements for pharmacist licensure, by recognizing all of the hours earned during the professional experience curriculum in an accredited college of pharmacy as full satisfaction of the licensure requirements and eliminating the requirement of additional hours of experience beyond those acquired during a college curriculum.
               08-25-2015 - Committee reviewed Draft #1 and requested several amendments.
               01-19-2016 - Committee reviewed Draft #2 and requested one change, then voted to recommend approval of Draft #3 to the Board.
               01-27-2016 - Proposal referred to Tripartite Committee for further review.
               03-30-2016 - Tripartite Committee reviewed Draft #3 and offered suggested revisions; Regulation Revision Committee met afterwards and requested additional revisions.
               04-21-2016 - Regulation Revision Committee reviwed Draft #4, requested changes incorporated as Draft #5, then voted to recommend the approval of Draft #5 to the Board.
               05-04-2016 - Board approved  Draft #5 (coded / clean) for promulgation.
               04-10-2017 - Incorporated as Regulatory Project 2017-1.
               11-20-2017 - Final Rule published, with a delayed effective date of January 1, 2018.


2016-A ~ Creates a new chapter of rules in response to Act 261 of the 2015 Legislature, which requires the Board to establish a special type of pharmacy permit to enable the dispensing of marijuana for therapeutic purposes, subject to the limitations itemized in the enabling legislation.
               08-25-2015 - Committee reviewed Draft #1 and requested several amendments.
               01-19-2016 - Committee reviewed Draft #2 (Coded / Clean) and requested multiple revisions.
               03-30-2016 - Committee received stakeholder input on Draft #2; will continue its revew at next meeting.
               04-21-2016 - Committee continued its review of Draft #2; requested new draft for next meeting.
               06-28-2016 - Committee reviewed Draft #3 (Coded), and made requested additional revisions, which were completed in Draft #4..
               08-09-2016 - Committee received additional stakeholder input and requested changes to Draft #4; staff recorded those changes in Draft #4 - Coded.  The clean version of the updated document is titled Draft #5.
               08-10-2016 - Board approved Draft #5 to begin the promulgation process, upon the instruction of the President.
               01-20-2017 - Incorporated as Regulatory Project 2016-6.
               08-20-2017 - Final Rule published, effective today.